RNCOS, in its latest research report titled “Genetic Testing Market Outlook 2018”, highlighted that the global NGS market is poised to surpass US$ 3 Billion mark by 2018. The US and Europe exhibit the highest market penetration for next generation sequencing. In recent times, the global market has seen an introduction of new low priced technologies such as PGM, Ion Proton and MiSeq. The emerging platforms are low-cost (e.g., GridION), most likely marking the end of growth of expensive instruments. The major players in the NGS segment include Illumina, Life Technologies, and Roche.
Holistically, the research report thoroughly discusses the global genetic testing industry in terms of the overall market size. Moreover, the disease wise and region wise analysis is also discussed in detail. Apart from the statistical data analysis highlighted above, qualitative data including the emerging sector for genetic testing industry and the government regulations are also elicited exhaustively. The competition across the global genetic testing sector is intensifying with the days passing by. With new service providers entering the market and accelerated R&D activities, the application of genetic testing and the industry as a whole is bound to witness a swift growth in the years to come
And More Visit:- http://www.rncos.com/Market-Analysis-Reports/Genetic-Testing-Market-Outlook-2018-IM720.htm